Evidence map›Paper›PMID 32298669›Full record

ArticleJournal of biotechnology2020

Influence of media composition on recombinant monoclonal IgA1 glycosylation analysed by lectin-based protein microarray and MALDI-MS.

Lucia Pažitná, Marek Nemčovič, Zuzana Pakanová, Peter Baráth, Teimur Aliev, Dmitry Dolgikh, Victoria Argentova, Jaroslav Katrlík

Open access · greenAbstract read
In one paragraph

Article in Journal of biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Tracking of Glycans Structure and Metallomics Profiles inInternational journal of molecular sciences · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Lucia PažitnáInstitute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
Marek NemčovičInstitute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
Zuzana PakanováInstitute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
Peter BaráthInstitute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
Teimur AlievDepartment of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Dmitry DolgikhDepartment of Bioengineering, School of Biology, Lomonosov Moscow State University, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Victoria ArgentovaDepartment of Bioengineering, School of Biology, Lomonosov Moscow State University, Moscow, Russia. Electronic address: vicarg@rambler.ru.
Jaroslav KatrlíkInstitute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: chemjkat@savba.sk.
Institute of Chemistry of the Slovak Academy of Sciences · SKLomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylation of therapeutic glycoproteins significantly affects their physico-chemical properties, bioactivity and immunogenicity. The determination of glycan composition is highly important regarding their development and production. Therefore, there is a demand for analytical techniques enabling rapid and reliable glycoprofiling of therapeutic proteins. For the investigation of changes in glycan structures, we have employed two platforms: lectin-based protein microarray, and MALDI-MS. In lectin-based microarray analysis, the samples of IgA were printed on the microarray slide, incubated with the set of lectins with various specificity and evaluation of changes in glycosylation was based on differences in reactivity of samples with lectins. MALDI-MS was used for N-glycan analysis of IgA1 samples. IgAs are effective as therapeutic agents in defense against viruses that use sialic acid as a receptor. Dimeric IgA1 antibodies were produced by stable cell line IgA1/2G9 on the basal medium at different conditions (different supplementation and feeding) and we also evaluated the effect of different conditions on lactate production, which correlates with IgA productivity. Decrease of lactate levels was observed during supplementation with succinic acid, asparagine, or with mannose feeding. We found by lectin-based microarray analysis that the metabolic shift from glutamine to asparagine or feeding with glucose caused increase of high mannose type glycans what was confirmed also by MALDI-MS. Among other changes in IgA glycosylation determined by lectin-based protein microarray were, for example, reduced galactosylation after supplementation with succinic acid and increase of both sialylation and galactosylation after supplementation with glutamine and feeding with mannose. The elucidation of mechanism of determined changes requires further investigation, but the described analytical approach represent effective platform for determination, screening and evaluation of glycosylation of therapeutic proteins.

Indexed as

AnimalsAntibodies, MonoclonalCHO CellsCricetulusCulture MediaGlycosylationImmunoglobulin ALectinsPolysaccharidesProtein Array AnalysisRecombinant ProteinsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAntibodies, MonoclonalCulture MediaImmunoglobulin ALectinsPolysaccharidesRecombinant ProteinsGlycosylationIgALectin-based microarrayMALDI-MSMonoclonal antibodyTherapeutic proteins

Identifiers

PMID32298669
PMCPMC7194684
OpenAlexW3017109955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.